December 24 repurchase collection | TENCENT, HSBC Holdings and others have repurchased, with TENCENT spending 0.503 billion HKD.

According to a disclosure from HKEX on December 27, TENCENT (00700.HK), HSBC Holdings (00005.HK), and others repurchased shares. ① TENCENT (00700.HK) repurchased 1.2 million shares of common stock on December 24, involving an amount of 0.503 billion Hong Kong dollars, with a repurchase price ranging from 421.4 to 417.8 Hong Kong dollars per share. Since the buyback authorization resolution, the total number of repurchased securities is 0.226 billion shares, accounting for 2.395% of the number of issued shares at the time the ordinary resolution was passed. ② HSBC Holdings (00005.HK)

Futu News09:20

Kaiyuan Securities: Each subtype of hematological tumors has the potential to hatch "heavyweight bomb" drugs. Pay attention to Innovative Drugs companies.

The subtype of blood tumors is less aggressive with a longer treatment cycle, generally requiring long-term medication. Patients have relatively high viscosity and the potential for the emergence of "blockbuster" drugs.

Zhitong FinanceDec 26 10:48

INNOCARE (09969.HK) spent 0.6315 million HKD to repurchase 0.106 million shares on December 24.

Glory Hong Kong reported on December 24 that INNOCARE (09969.HK) announced that on December 24, 2024, it spent 0.6315 million Hong Kong dollars to repurchase 0.106 million shares, with the repurchase price ranging from 5.86 to 6 Hong Kong dollars per share.

Gelonghui FinanceDec 24 18:57

InnoCare Pharma Granted Waiver for Director Appointment

TipRanksDec 24 18:07

Highly resilient! Leading CRO companies have stabilized their fundamentals, but the shadow of the biosafety bill may still linger next year | Year-end review.

① In 2024, the USA Biodefense Act will disrupt CROs throughout the year and may continue next year; ② In the first three quarters of this year, over half of listed companies experienced revenue growth, and leading CROs demonstrated resilience; ③ Research on popular targets such as ADC, GLP-1, and bispecific antibodies will continue to be hot; ④ In 2025, the performance of leading CROs and small to medium enterprises may further diverge.

cls.cnDec 24 17:16

December 23 repurchase collection | TENCENT, HSBC Holdings, and others have successively repurchased, among which TENCENT spent 0.704 billion HKD.

According to a disclosure by HKEX on December 24, TENCENT (00700.HK) and HSBC Holdings (00005.HK) have repurchased shares. ① TENCENT (00700.HK) repurchased 1.67 million ordinary shares on December 23, involving an amount of 0.704 billion Hong Kong dollars, with a repurchase price ranging from 430.6 HKD to 416.4 HKD per share. Since the repurchase authorization resolution, the cumulative number of securities repurchased has been 0.224 billion shares, accounting for 2.382% of the total issued shares at the time of approval of the ordinary resolution. ② HSBC Holdings (00005.HK)

Futu NewsDec 24 09:40